Kidney aminopeptidase A and hypertension, part I: Spontaneously hypertensive rats

Hypertension

Volumn 33, Issue 2, 1999, Pages 740-745

  Healy, Dennis P ^a,b   Song, Lijun ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Aminopeptidases; Angiotensin; Angiotensin III; Hypertension; Kidney; Kidney glomerulus

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN III; CAPTOPRIL; GLUTAMYL AMINOPEPTIDASE; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LOCALIZATION; GLOMERULUS; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0033031551     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.33.2.740     Document Type: Article

References (56)

1. Iyer SN, Lu D, Katovich MJ, Raizada MK. Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotensin type 1 receptor antisense. Proc Natl Acad Sci U S A. 1996:93:9960-9965.
2. Wielbo D, Simon A, Phillips MI, Toffolo S. Inhibition of hypertension by peripheral administration of antisense oligodeoxynucleotides. Hypertension. 1996;28:147-151.
3. Bunkenburg B, Schnell C, Baum HP, Cumin F, Wood JM. Prolonged angiotensin II antagonism in spontaneously hypertensive rats. Hemodynamic and biochemical consequences. Hypertension. 1991;18:278-288.
4. Campbell DJ, Duncan AM, Kladis A, Harrap SB. Angiotensin peptides in spontaneously hypertensive and normotensive Donryu rats. Hypertension. 1995;25:928-934.
5. Kim S, Tokuyama M, Hosoi M, Yamamoto K. Adrenal and circulating renin-angiotensin system in stroke-prone hypertensive rats. Hypertension. 1992;20:280-291.
6. Kohara K, Brosnihan KB, Ferrario CM. Angiotensin(1-7) in the spontaneously hypertensive rat. Peptides. 1993;14:883-891.
7. Matsushima Y, Kawamura M, Akabane S, Imanishi M, Kuramochi M, Ito K, Omae T. Increases in renal angiotensin II content and tubular angiotensin II receptors in prehypertensive spontaneously hypertensive rats. J Hypertens. 1988;6:791-796.
8. Hubner N, Kreutz R, Takahashi S, Ganten D, Lindpaintner K. Unlike human hypertension, blood pressure in a hereditary hypertensive rat strain shows no linkage to the angiotensinogen locus. Hypertension. 1994;23: 797-801.
9. Hubner N, Kreutz R, Takahashi S, Ganten D, Lindpaintner K. Altered angiotensinogen amino acid sequence and plasma angiotensin II levels in genetically hypertensive rats. A study on cause and effect. Hypertension. 1995;26:279-284.
10. Campbell DJ, Kladis A, Duncan AM. Nephrectomy, converting enzyme inhibition, and angiotensin peptides. Hypertension. 1993;22:513-522.
11. Campbell DJ, Lawrence AC, Towrie A, Kladis A, Valentijn AJ. Differential regulation of angiotensin peptide levels in plasma and kidney of the rat. Hypertension. 1991;18:763-773.
12. Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature. 1990;344:541-544.
13. Esther CR, Marino EM, Howard TE, Machaud A, Corvol P, Capecchi MR, Bernstein KE. The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice. J Clin Invest. 1997;99: 2375-2385.
14. Fox J, Guan S, Hymel AA, Navar LG. Dietary Na and ACE inhibition effects on renal tissue angiotensin I and II and ACE activity in rats. Am J Physiol. 1992;262:F902-F909.
15. Allan DR, McKnight JA, Kifor I, Coletti CM, Hollenberg NK. Converting enzyme inhibition and renal tissue angiotensin II in the rat. Hypertension. 1994;24:516-522.
16. Campbell DJ, Duncan AM, Kladis A, Harrap SB. Converting enzyme inhibition and its withdrawal in spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1995;26:426-436.
17. Campbell DJ, Kladis A, Duncan AM. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension. 1994; 23:439-449.
18. Rettig R, Schmitt B, Pelzl B, Speck T. The kidney and primary hypertension: contributions from renal transplantation studies in animals and humans. J Hypertens. 1993;11:883-891.
19. Chatziantoniou C, Arendshorst WJ. Angiotensin and thromboxane in genetically hypertensive rats: renal blood flow and receptor studies. Am J Physiol. 1991;261:F238-F247.
20. Chatziantoniou C, Daniels FH, Arendshorst WJ. Exaggerated renal vascular reactivity to angiotensin and thromboxane in young genetically hypertensive rats. Am J Physiol. 1990;259:F372-F382.
21. Vyas SJ, Jackson EK. Angiotensin II: enhanced renal responsiveness in young genetically hypertensive rats. J Pharmacol Exp Ther. 1995;273: 768-777.
22. Kost CK Jr, Jackson EK. Enhanced renal angiotensin II subtype 1 receptor responses in the spontaneously hypertensive rat. Hypertension. 1993;21:420-431.
23. Meng QC, Durand J, Chen YF, Oparil S. Effects of dietary salt on angiotensin peptides in kidney. J Am Soc Nephrol. 1995;6:1209-1215.
24. Correa FM, Viswanathan M, Ciuffo GM, Tsutsumi K, Saavedra JM. Kidney angiotensin II receptors and converting enzyme in neonatal and adult Wistar-Kyoto and spontaneously hypertensive rats. Peptides. 1995; 16:19-24.
25. Haws RM, Shaul PW, Arant BS Jr, Atiyeh BA, Seikaly MG. Glomerular losartan (DuP 753)-sensitive angiotensin II receptor density is increased in young spontaneously hypertensive rats. Pediatr Res. 1994;35: 671-676.
26. Messenger EA, Stonier C, Aber GM. Differences in glomerular binding and response to angiotensin II between normotensive and spontaneously hypertensive rats. Clin Sci. 1988;75:191-196.
27. Messenger EA, Stonier C, Aber GM. Influence of age on glomerular binding of angiotensin II in normotensive and spontaneously hypertensive rats. Clin Sci. 1989;76:619-623.
28. Haddad G, Garcia R. Characterization and hemodynamic implications of renal vascular angiotensin II receptors in SHR. J Mol Cell Cardiol. 1996;28:351-361.
29. Thomas D, Harris PJ, Morgan TO. Age-related changes in angiotensin II-stimulated proximal tubule fluid reabsorption in the spontaneously hypertensive rat. J Hypertens Suppl. 1988;6:S449-S451.
30. Cheng HF, Wang JL, Vinson GP, Harris RC. Young SHR express increased type 1 angiotensin II receptors in renal proximal tubule. Am J Physiol. 1998;274:F10-F17.
31. Thomas D, Harris PJ, Morgan TO. Altered responsiveness of proximal tubule fluid reabsorption of peritubular angiotensin II in spontaneously hypertensive rats. J Hypertens. 1990;8:407-410.
32. Ahmad S, Ward PE. Role of aminopeptidase activity in the regulation of the pressor activity of circulating angiotensins. J Pharmacol Exp Ther. 1990;252:643-650.
33. Chung A, Ryan JW, Berryer P. Inhibition of the formation of angiotensin III. Adv Exp Med Biol. 1983;156:693-701.
34. Nagatsu I, Gillespie L, Folk JE, Glenner GG. Serum aminopeptidases, "angiotensinase," and hypertension. I. Degradation of angiotensin II by human serum. Biochem Pharmacol. 1965;14:721-728.
35. Nagatsu I, Nagatsu T, Yamamoto T, Glenner GG, Mehl JW. Purification of aminopeptidase A in human serum and degradation of angiotensin II by the purified enzyme. Biochim Biophys Acta. 1970;198:255-270.
36. Li L, Wu Q, Wang J, Bucy RP, Cooper MD. Widespread tissue distribution of aminopeptidase A, an evolutionarily conserved ectoenzyme recognized by the BP-1 antibody. Tissue Antigens. 1993;42:488-496.
37. Song L, Ye M, Troyanovskaya M, Wilk E, Wilk S, Healy DP. Rat kidney glutamyl aminopeptidase (aminopeptidase A): molecular identity and cellular localization. Am J Physiol. 1994;267:F546-F557.
38. Troyanovskaya M, Song L, Jayaraman G, Healy DP. Expression of aminopeptidase A, an angiotensinase, in glomerular mesangial cells. Hypertension. 1996:27:518-522.
39. Stefanovic V, Vlahovic P, Ardaillou N, Ronco P, Ardaillou R. Cell surface aminopeptidase A and N activities in human glomerular epithelial cells. Kidney Int. 1992;41:1571-1580.
40. Mentzel S, Van Son J, De Jong AS, Dijkman H, Koene RAP, Wetzels JFM, Assmann KJM. Mouse glomerular epithelial cells in culture with features of podocytes in vivo express aminopeptidase A and angioten-sinogen but not other components of the renin-angiotensin system. J Am Soc Nephrol. 1997;8:706-719.
41. Song L, Wilk E, Wilk S, Healy DP. Localization of immunoreactive glutamyl aminopeptidase in rat brain. I. Association with cerebral microvessels. Brain Res. 1993;606:286-294.
42. Wu Q, Li L, Cooper MD, Pierres M, Gorvel JP. Aminopeptidase A activity of the murine B-lymphocyte differentiation antigen BP-1/6C3. Proc Natl Acad Sci U S A. 1991;88:676-680.
43. Beldent V, Michaud A, Bonnefoy C, Chauvet MT, Corvol P. Cell surface localization of proteolysis of human endothelial angiotensin I-converting enzyme. Effect of the amino-terminal domain in the solubilization process. J Biol Chem. 1995;270:28962-28969.
44. Zini S, Masdehors P, Lenkei Z, Fournie-Zaluski MC, Roques BP, Corvol P, Llorens-Cortes C. Aminopeptidase A: distribution in rat brain nuclei and increased activity in spontaneously hypertensive rats. Neuroscience. 1997;78:1187-1193.
45. Ganten D, Hermann K, Bayer C, Unger T, Lang RE. Angiotensin synthesis in the brain and increased turnover in hypertensive rats. Science. 1983;221:869-871.
46. Wright JW, Sullivan MJ, Quirk WS, Batt CM, Harding JW. Heightened blood pressure and drinking responsiveness to intracerebroventricularly applied angiotensins in the spontaneously hypertensive rat. Brain Res. 1987;420:289-294.
47. Cook VI, Wright JW, Wright SA, Harding JW. Comparison of angiotensin metabolism by brain membranes from SHR and WKY rats. Brain Res. 1990;529:320-323.
48. Zini S, Fournie Zaluski MC, Chauvel E, Roques BP, Corvol P, Llorens Cortes C. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proc Natl Acad Sci U S A. 1996;93:11968-11973.
49. Song L, Wilk S, Healy DP. Aminopeptidase A antiserum inhibits intracerebroventricular angiotensin II-induced dipsogenic and pressor responses. Brain Res. 1997;744:1-6.
50. Wright JW, Harding JW. Important roles for angiotensin III and IV in the brain renin-angiotensin system. Brain Res Rev. 1997;25:96-124.
51. Wolf G, Thaiss F, Mueller E, Disser M, Pooth R, Zahner G, Stahl RA. Glomerular mRNA expression of angiotensinase A after renal ablation. Exp Nephrol. 1995;3:240-248.
52. Wolf G, Thaiss F, Scherberich JE, Schoeppe W, Stahl RA. Glomerular angiotensinase A in the rat: increase of enzyme activity following renal ablation. Kidney Int. 1990;38:862-868.
53. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, Schwartz SM. Renal injury from angiotensin II-mediated hypertension. Hypertension. 1992;19:464-474.
54. Khairallah PA, Bumpus FM, Page IH, Smeby RR. Angiotensinase with a high degree of specificity in plasma and red blood cells. Science. 1963; 140:672-674.
55. Nagatsu I, Gillespie L, George JM, Folk JE, Glenner GG. Serum amino-peptidases, "angiotensinase," and hypertension. II. Amino acid beta-napthylamide hydrolysis by normal and hypertensive serum. Biochem Pharmacol. 1965;14:853-861.
56. Mizutani S, Furuhashi M, Imaizumi H, Ito Y, Kurauchi O, Tomoda Y. Effects of human placental aminopeptidases in spontaneously hypertensive rats. Med Sci Res 1987;15:1203-1204.